Plasma Immune Biomarkers Predictive of Progression to Active Tuberculosis in Household Contacts of Patients With Tuberculosis
The Journal of Infectious Diseases · 17.03.2025 · 231 (3) · 696-705
DOI: 10.1093/infdis/jiae365 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 19.07.2024. Verfasst von Anuradha Rajamanickam und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Health-National Institute of Allergy and Infectious Diseases-International Center for Excellence in Research, Chennai, India. Hauptthemen laut MEDLINE: Biomarkers, Tuberculosis, Pulmonary, Cytokines, Tuberculosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, Department of Biotechnology, (support to S. B.).
Abstract (Originalsprache)
Background
The progression from Mycobacterium tuberculosis infection to active tuberculosis disease varies among individuals, and identifying biomarkers to predict progression is crucial for guiding interventions. In this study, we aimed to determine plasma immune biomarker profiles in healthy household contacts of index patients with pulmonary tuberculosis, who either progressed to tuberculosis or remained as nonprogressors.
Methods
A cohort of household contacts of adults with pulmonary tuberculosis was enrolled, consisting of 15 contacts who progressed to tuberculosis disease and 15 nonprogressors. Plasma samples were collected at baseline, 4 months, and 12 months to identify predictive tuberculosis progression markers.
Results
Our findings revealed that individuals in the progressor group exhibited significantly decreased levels of interferon (IFN) γ, tumor necrosis factor α, interleukin 2, IL-1α, IL-1β, and 17A, and interleukin 1 receptor antagonist (IL-1Ra) at baseline, month 4, and month 12. In contrast, the progressor group displayed significantly elevated levels of IFN-α, IFN-β, interleukin 6 and 12, granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 10 (IL-10) and 33 (IL-33), CCL2, CCL11, CXCL8, CXCL10, CX3CL1, vascular endothelial growth factor, granzyme B, and programmed death ligand -1 compared to the nonprogressor group at baseline, months 4 and 12. Receiver operating characteristic analysis (ROC) identified IFN-γ, GM-CSF, IL-1Ra, CCL2, and CXCL10 as the most promising predictive markers, with an area under the receiver operating characteristic curve of ≥90. Furthermore, combinatorial analysis demonstrated that GM-CSF, CXCL10, and IL-1Ra, when used in combination, exhibited high accuracy in predicting progression to active tuberculosis disease.
Conclusions
Our study suggests that a specific set of plasma biomarkers, GM-CSF, CXCL10, and IL-1Ra, can effectively identify household contacts at significant risk of developing tuberculosis disease. These findings have important implications for early intervention and preventive strategies in tuberculosis-endemic regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Health-National Institute of Allergy and Infectious Diseases-International Center for Excellence in Research, Chennai, India.
- ICMR-National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai, India.
- University of Madras, Chennai, India.
- Department of Pulmonary Medicine, Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India.
- Byramjee Jeejeebhoy Government Medical College-Johns Hopkins Clinical Research Site, Pune, India.
- Johns Hopkins Center for Infectious Diseases in India, Pune, India.
ORCID-Profile: Anuradha Rajamanickam, Vidya Mave, Amita Gupta
Förderung
- National Institute of Allergy and Infectious Diseases
- Department of Biotechnology
- (support to S. B.)
- CRDF Global
- NIH HHS
- NHLBI NIH HHS
- Indian Council of Medical Research
- Government of India's
Zitieren
APA
Rajamanickam, A., Ann Daniel, E., Dasan, B., Thiruvengadam, K., Chandrasekaran, P., Gaikwad, S., Pattabiraman, S., Bhanu, B., Sivaprakasam, A., Kulkarni, V., Karyakarte, R., Paradkar, M., Shivakumar, S. V. B. Y., Mave, V., Gupta, A., Hanna, L. E., & Babu, S. (2025). Plasma Immune Biomarkers Predictive of Progression to Active Tuberculosis in Household Contacts of Patients With Tuberculosis. The Journal of Infectious Diseases, 231(3), 696-705. https://doi.org/10.1093/infdis/jiae365
Vancouver
Rajamanickam A, Ann Daniel E, Dasan B, Thiruvengadam K, Chandrasekaran P, Gaikwad S, et al. Plasma Immune Biomarkers Predictive of Progression to Active Tuberculosis in Household Contacts of Patients With Tuberculosis. The Journal of Infectious Diseases. 2025;231(3):696-705. doi:10.1093/infdis/jiae365
BibTeX
@article{Rajamanickam2025,
author = {Rajamanickam, Anuradha and Ann Daniel, Evangeline and Dasan, Bindu and Thiruvengadam, Kannan and Chandrasekaran, Padmapriyadarsini and Gaikwad, Sanjay and Pattabiraman, Sathyamurthi and Bhanu, Brindha and Sivaprakasam, Amsaveni and Kulkarni, Vandana and Karyakarte, Rajesh and Paradkar, Mandar and Shivakumar, Shri Vijay Bala Yogendra and Mave, Vidya and Gupta, Amita and Hanna, Luke Elizabeth and Babu, Subash},
title = {Plasma Immune Biomarkers Predictive of Progression to Active Tuberculosis in Household Contacts of Patients With Tuberculosis},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {231},
number = {3},
pages = {696--705},
doi = {10.1093/infdis/jiae365}
}
EUVIMED